NEW Editorial: Combined creatinine / cystatin C equations for estimation of GFR in patients with cancer: the future is now! 🆓doi.org/10.1093/ndt/gf… ben sprangers Amaryllis Van Craenenbroeck

📽️ The webcast of the latest ERA Journal Club e-seminar is now online! *Clinical impact of the #Kidney Failure Risk Equation for #vascular access planning* Watch it now 👉 bit.ly/3V78Oai bit.ly/3V78Oai

We are delighted to welcome Dr Samira Bell as Associate Director of our new Kidney Data Science Catalyst in partnership with Kidney Research UK. Samira will lead on urgently needed data-led research to improve kidney and heart health. Read more here: hubs.li/Q02zN_Hg0

Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology. #MayoClinicKidney Sandra Herrmann MD, FASN @Cjasn Abhijat Kitchlu | Onconephrology American Society of Onconephrology Nattawat Klomjit journals.lww.com/cjasn/abstract…

Dropping onto Twitter for #UKKW24 Very proud of Chandhini our SFP trainee presenting as an FY1 at her first conference. She started looking at the data she presented in September and already presenting combined data from University of Glasgow and University of Leicester . Very well done!

Another Edinburgh Kidney winner David Baird , bravo!

A huge honour to have won the best poster for some of my #UKBiobank analyses at #UKKW2024: sex stratified associations between fat free mass and mortality - we need to understand these differences so that we can appropriately individualise care Keele Medical School University Hospitals Birmingham

Our first ASON American Society of Onconephrology Position Statement Committee publication. Many thanks to all our multidisciplinary collaborators and co-chair Sandra Herrmann MD, FASN Part 2:

Exciting opportunity to apply for a Wellcome funded PhD looking at post-operative outcomes in #multimorbidity UoD Medicine Tim J Croudace 👇👇👇 gla.ac.uk/postgraduate/d…

In #EMPAKIDNEY those with the greatest burden of frailty gained the greatest absolute benefits of empagliflozin in reducing kidney disease progression/CV death + it's safe even in frailty, benefits far outweigh potential harms 👇 (Slides from ERA, multipanel figures in paper)

Urinary soluble PD-1 as a biomarker of Checkpoint Inhibitor induced acute tubulointerstitial nephritis academic.oup.com/ckj/advance-ar…

Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care 🔓doi.org/10.1093/ndt/gf…

Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysis 🔓doi.org/10.1093/ndt/gf…

Really excited about this new role University of Glasgow UofG MVLS UofG School of Health & Wellbeing - our school is doing outstanding work in terms of #research and #education and promoting a positive #researchculture -It is a great privilege and I am very much looking forward to working with everyone.🙂

This Q arose at ERA - European Renal Association Congress Hands-On haemodialysis line insertion course Milan 23 Dr Dr Kate Stevens💙. So University of Glasgow med student took on as project and we conclude that no need routinely to image tunneled HD catheters for thrombus before removal doi.org/10.1177/112972…

Cancer therapy in patients with reduced kidney function 📖doi.org/10.1093/ndt/gf…

eur03.safelinks.protection.outlook.com/?url=https%3A%… Single centre retrospective analysis on the impact of Vegf signalling pathway inhibitors+/- Immune checkpoint inhibitors on kidney function. Top collabortative effort from UofG SCMH and University of Sydney. Great to see this work in full print.

Strong work by our #onconeph fellow Dr Elena-Bianca Barbir, MD in collaboration with Dr Abhijat Kitchlu | Onconephrology . Sharing evidence and our personal experience on management of ICI-AKI(AIN) and rechallenge . Thanks Hans-Joachim Anders NDT for the invitation! Mayo Clinic Nephrology American Society of Onconephrology

Whole pop UK linked data on >230,000 ppl with HF from Robert Fletcher at #ESCCongress - Ppl with CKD remain undertreated for HF despite being at 🔼 risk - CKD contributes 2x to 🏥/☠️ than any other comorbidity - Major opportunities to improve pop health In press, The Lancet Public Health

Nice review of one of my least favourite diagnoses. Not sure I believe it accounts for as many as 1 in 20 cases of urinary tract obstruction though…